Cargando…
Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment
Defective thyroid hormone transport due to deficiency in thyroid hormone transporter monocarboxylate transporter 8 (MCT8) results in severe neurodevelopmental delay due to cerebral hypothyroidism and in clinical negative sequelae following a chronic thyrotoxic state in peripheral tissues. The life e...
Autores principales: | van Geest, Ferdy S., Groeneweg, Stefan, Visser, W. Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016746/ https://www.ncbi.nlm.nih.gov/pubmed/33650046 http://dx.doi.org/10.1007/s12020-020-02603-y |
Ejemplares similares
-
Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development
por: van Geest, Ferdy S., et al.
Publicado: (2021) -
Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
por: Vancamp, Pieter, et al.
Publicado: (2020) -
OR01-05 Long-Term Efficacy of T3 Analogue Triac in MCT8 Deficiency
por: van Geest, Ferdy S, et al.
Publicado: (2020) -
Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy
por: Thomas, Jinsu, et al.
Publicado: (2023) -
Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination
por: Lee, Jae Young, et al.
Publicado: (2017)